GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » YoY EBITDA Growth

Bio-Gate AG (XTER:BIG1) YoY EBITDA Growth : -56.06% (As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Bio-Gate AG's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was -56.06%.

Bio-Gate AG's EBITDA per Share for the six months ended in Jun. 2024 was €-0.10.


Bio-Gate AG YoY EBITDA Growth Historical Data

The historical data trend for Bio-Gate AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gate AG YoY EBITDA Growth Chart

Bio-Gate AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.54 32.76 43.59 -347.73 21.32

Bio-Gate AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,233.33 -50.00 46.77 -15.28 -56.06

Bio-Gate AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Bio-Gate AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.155--0.197)/ | -0.197 |
=21.32 %

Bio-Gate AG's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(-0.103--0.066)/ | -0.066 |
=-56.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Gate AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Bio-Gate AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Gate AG Business Description

Traded in Other Exchanges
N/A
Address
Neumeyerstrasse 28-34, Nurnberg, DEU
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Executives
Karl Richter Supervisory Board

Bio-Gate AG Headlines

No Headlines